ZA919853B - Transdermal delivery of dobutamine. - Google Patents

Transdermal delivery of dobutamine.

Info

Publication number
ZA919853B
ZA919853B ZA919853A ZA919853A ZA919853B ZA 919853 B ZA919853 B ZA 919853B ZA 919853 A ZA919853 A ZA 919853A ZA 919853 A ZA919853 A ZA 919853A ZA 919853 B ZA919853 B ZA 919853B
Authority
ZA
South Africa
Prior art keywords
dobutamine
transdermal delivery
transdermal
delivery
Prior art date
Application number
ZA919853A
Other languages
English (en)
Inventor
Kirti Himatlal Valia
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA919853B publication Critical patent/ZA919853B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA919853A 1990-12-20 1991-12-13 Transdermal delivery of dobutamine. ZA919853B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63048090A 1990-12-20 1990-12-20

Publications (1)

Publication Number Publication Date
ZA919853B true ZA919853B (en) 1993-06-14

Family

ID=24527346

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919853A ZA919853B (en) 1990-12-20 1991-12-13 Transdermal delivery of dobutamine.

Country Status (12)

Country Link
EP (1) EP0492930A3 (hu)
JP (1) JPH04275219A (hu)
KR (1) KR920011479A (hu)
AU (1) AU8985791A (hu)
BR (1) BR9105371A (hu)
CA (1) CA2057647A1 (hu)
CS (1) CS379491A3 (hu)
HU (1) HU914012D0 (hu)
IE (1) IE914453A1 (hu)
IL (1) IL100367A0 (hu)
MX (1) MX9102627A (hu)
ZA (1) ZA919853B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE041353T2 (hu) * 2011-02-15 2019-05-28 Elanco Us Inc Eljárás fájdalom csillapítására kutyafélékben fentanil transzdermális oldatának alkalmazásával

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4704407A (en) * 1984-12-20 1987-11-03 Eli Lilly And Company Soluble dobutamine salts
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
US4814173A (en) * 1987-09-08 1989-03-21 Warner-Lambert Company Silicone elastomer transdermal matrix system

Also Published As

Publication number Publication date
IE914453A1 (en) 1992-07-01
MX9102627A (es) 1992-06-01
IL100367A0 (en) 1992-09-06
BR9105371A (pt) 1992-08-25
EP0492930A2 (en) 1992-07-01
EP0492930A3 (en) 1992-10-14
AU8985791A (en) 1992-06-25
HU914012D0 (en) 1992-03-30
KR920011479A (ko) 1992-07-24
JPH04275219A (ja) 1992-09-30
CS379491A3 (en) 1992-07-15
CA2057647A1 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
GB2243788B (en) Stiletted needles
GB9025710D0 (en) Novel treatment
GB9024928D0 (en) Novel treatment
GB9104696D0 (en) Bandage
ZA919853B (en) Transdermal delivery of dobutamine.
GB9016375D0 (en) Syringe
GB2254247B (en) Infuser
GB9024926D0 (en) Novel treatment
GB9024925D0 (en) Novel treatment
GB9022298D0 (en) Treatment composition
GB9006627D0 (en) Treating diabetes
EG19223A (en) Therapeutic agents.
GB9005050D0 (en) Treatment of diabetes
CA65932S (en) Syringe
RU1769716C (en) Syringe
CA66409S (en) Syringe
CA66344S (en) Syringe
GB9022561D0 (en) Improved syringe
IL95596A0 (en) Insulin requirement determination
GB9010163D0 (en) Novel treatment i
GB9005212D0 (en) Novel treatment
GB9018676D0 (en) Novel treatment
GB9014242D0 (en) Novel treatment
GB9013910D0 (en) Novel treatment
GB9013268D0 (en) Novel treatment